×
About 1,343 results

ALLMedicine™ Lsd Center

Research & Reviews  635 results

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865169
Proceedings of the National Academy of Sciences of the Un... De Gregorio D, Popic J et. al.

Jan 26th, 2021 - Clinical studies have reported that the psychedelic lysergic acid diethylamide (LSD) enhances empathy and social behavior (SB) in humans, but its mechanism of action remains elusive. Using a multidisciplinary approach including in vivo electrophys...

Dietary sodium intake does not alter renal potassium handling and blood pressure in hea...
https://doi.org/10.1093/ndt/gfaa381
Nephrology, Dialysis, Transplantation : Official Publicat... Pechère-Bertschi A, Olivier V et. al.

Jan 25th, 2021 - The effects of sodium intakes on renal handling of potassium are insufficiently studied. We assessed the effect of sodium on renal potassium handling in 16 healthy males assigned to three 7-day periods on low (LSD, 3 g NaCl/d), normal (NSD, 6 g Na...

Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Po...
https://doi.org/10.1055/a-1341-1907
Pharmacopsychiatry Mertens LJ, Preller KH

Jan 20th, 2021 - Classical psychedelics, primarily psilocybin and lysergic acid diethylamide (LSD), have been used and extensively studied in Western medicine as part of substance-assisted psychotherapy in the 1950s and 1960s. Modern clinical research is currently...

A charitable access program for patients with lysosomal storage disorders in underserve...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788852
Orphanet Journal of Rare Diseases; Mehta A, Ramaswami U et. al.

Jan 7th, 2021 - Lysosomal storage disorders (LSDs) are rare genetic disorders, with heterogeneous clinical manifestations and severity. Treatment options, such as enzyme replacement therapy (ERT), substrate replacement therapy, and pharmacological chaperone thera...

The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysacchar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775043
PloS One; Mengel E, Gaedeke J et. al.

Dec 31st, 2020 - Lysosomal Storage Diseases (LSD) are rare and multisytemic diseases which are caused by lysosomal enzyme deficiencies leading into accumulation of waste products due to an interruption in the decomposition process. Due to the low prevalence and th...

see more →

Clinicaltrials.gov  671 results

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865169
Proceedings of the National Academy of Sciences of the Un... De Gregorio D, Popic J et. al.

Jan 26th, 2021 - Clinical studies have reported that the psychedelic lysergic acid diethylamide (LSD) enhances empathy and social behavior (SB) in humans, but its mechanism of action remains elusive. Using a multidisciplinary approach including in vivo electrophys...

Dietary sodium intake does not alter renal potassium handling and blood pressure in hea...
https://doi.org/10.1093/ndt/gfaa381
Nephrology, Dialysis, Transplantation : Official Publicat... Pechère-Bertschi A, Olivier V et. al.

Jan 25th, 2021 - The effects of sodium intakes on renal handling of potassium are insufficiently studied. We assessed the effect of sodium on renal potassium handling in 16 healthy males assigned to three 7-day periods on low (LSD, 3 g NaCl/d), normal (NSD, 6 g Na...

Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Po...
https://doi.org/10.1055/a-1341-1907
Pharmacopsychiatry Mertens LJ, Preller KH

Jan 20th, 2021 - Classical psychedelics, primarily psilocybin and lysergic acid diethylamide (LSD), have been used and extensively studied in Western medicine as part of substance-assisted psychotherapy in the 1950s and 1960s. Modern clinical research is currently...

A charitable access program for patients with lysosomal storage disorders in underserve...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788852
Orphanet Journal of Rare Diseases; Mehta A, Ramaswami U et. al.

Jan 7th, 2021 - Lysosomal storage disorders (LSDs) are rare genetic disorders, with heterogeneous clinical manifestations and severity. Treatment options, such as enzyme replacement therapy (ERT), substrate replacement therapy, and pharmacological chaperone thera...

The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysacchar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775043
PloS One; Mengel E, Gaedeke J et. al.

Dec 31st, 2020 - Lysosomal Storage Diseases (LSD) are rare and multisytemic diseases which are caused by lysosomal enzyme deficiencies leading into accumulation of waste products due to an interruption in the decomposition process. Due to the low prevalence and th...

see more →

News  37 results

Morning Break: Vitamin E, J'Accuse! Groupon CT Scans; Death by Rooster
https://www.medpagetoday.com/primarycare/smoking/82004

Sep 6th, 2019 - Note that some links may require subscriptions. Investigators are examining whether vitamin E acetate is the culprit in the vaping-related lung illnesses. (The Hill) Feelin' groovy: Johns Hopkins starts a $17-million research center to study "magi...

Use of Marijuana, Meth, Hallucinogens Up in New SAMHSA Survey
https://www.medscape.com/viewarticle/917131

Aug 21st, 2019 - Almost 1 million more Americans ages 12 or older reported using marijuana in their lifetime in 2018 than in 2017, according to new data from a national survey. The Substance Abuse and Mental Health Services Administration (SAMHSA) 2018 National Su...

Psilocybin promising for alcohol use disorder
https://www.mdedge.com/clinicianreviews/article/202630/addiction-medicine/psilocybin-promising-alcohol-use-disorder?channel=53
M. Alexander Otto

Jun 10th, 2019 - SAN FRANCISCO – Patients with alcohol use disorder reported a substantial decrease in drinking days, drinks per drinking day, and cravings in an ongoing trial of psilocybin at New York University. M.

Denver May OK Personal Use of 'Magic Mushrooms'
https://www.staging.medscape.com/viewarticle/911434

Apr 4th, 2019 - Psychedelic mushrooms could be decriminalized for the first time in more than 50 years in a US city if Denver activists have their way. The group Decriminalize Denver collected 8,000 signatures to put a measure on the May 7 city election ballot th...

Denver May OK Personal Use of 'Magic Mushrooms'
https://www.medscape.com/viewarticle/911434

Apr 4th, 2019 - Psychedelic mushrooms could be decriminalized for the first time in more than 50 years in a US city if Denver activists have their way. The group Decriminalize Denver collected 8,000 signatures to put a measure on the May 7 city election ballot th...

see more →